Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Pyridine derivatives >  4-(Bromoacetyl)pyridine hydrobromide

4-(Bromoacetyl)pyridine hydrobromide

Basic information Safety Supplier Related

4-(Bromoacetyl)pyridine hydrobromide Basic information

Product Name:
4-(Bromoacetyl)pyridine hydrobromide
Synonyms:
  • BUTTPARK 37\12-45
  • 2-BROMO-1-PYRDIN-4-YLETHAN-1-ONE HYDROBROMIDE
  • 2-BROMO-1-(4-PYRIDINYL)-1-ETHANONE HYDROBROMIDE
  • 4-(BROMOACETYL)PYRIDINE HYDROBROMIDE
  • 4-(2-BROMO-ACETYL)-PYRIDINIUM, BROMIDE
  • 2-Bromo-1-pyridin-4-ylethanone hydrobromide
  • 2-Bromo-1-pyrdin-3-ylethan-1-one hydrobromide
  • 2-Bromo-1-(pyridin-4-yl)ethan-1-one hydrobromide
CAS:
5349-17-7
MF:
C7H7Br2NO
MW:
280.94
EINECS:
621-664-3
Product Categories:
  • Heterocyclic Compounds
  • Acetyl Halides
  • Pyridines
  • CHIRAL CHEMICALS
  • Acetyl Halides
Mol File:
5349-17-7.mol
More
Less

4-(Bromoacetyl)pyridine hydrobromide Chemical Properties

Melting point:
194 °C
storage temp. 
under inert gas (nitrogen or Argon) at 2–8 °C
form 
powder
color 
Off-white
Water Solubility 
Soluble in water.
CAS DataBase Reference
5349-17-7(CAS DataBase Reference)
More
Less

Safety Information

Hazard Codes 
Xi,Xn
Risk Statements 
36/37/38-22
Safety Statements 
26-36/37/39-37/39
Hazard Note 
Irritant
HazardClass 
8
HS Code 
2933399990
More
Less

4-(Bromoacetyl)pyridine hydrobromide Usage And Synthesis

Uses

Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase 4-(Bromoacetyl)pyridine hydrobromide was used to prepare 2-Phenyl-4-(4-pyridyl)imidazole.

Synthesis

1122-54-9

5349-17-7

General procedure for the synthesis of 4-(bromoacetyl)pyridine hydrobromide from 4-acetylpyridine: 558 g of batch master batch was added to a reaction flask, followed by the addition of 42 g of ethyl acetate, and 121.1 g of 4-acetylpyridine was added slowly with stirring, keeping the reaction temperature at 20~30 °C and stirring well. N-bromosuccinimide (NBS) 186.9 g was added in batches, followed by slow warming to 65~75 °C. The progress of the reaction was monitored by thin layer chromatography (TLC) until the feedstock was fully reacted. After completion of the reaction, the reaction mixture was cooled to 0~10°C to allow complete crystallization of the product. The crystals were collected by filtration, washed and pulped with 650 g of deionized water, filtered again, and dried to give 275.6 g of 4-(bromoacetyl)pyridine hydrobromide as a white solid in 98.1% molar yield.

References

[1] Patent: WO2005/73225, 2005, A1. Location in patent: Page/Page column 49-50
[2] Patent: CN106632001, 2017, A. Location in patent: Paragraph 0026; 0027; 0028; 0029
[3] Journal of Medicinal Chemistry, 2010, vol. 53, # 2, p. 787 - 797
[4] Patent: WO2009/158393, 2009, A1. Location in patent: Page/Page column 51
[5] Patent: US2007/142415, 2007, A1. Location in patent: Page/Page column 17

4-(Bromoacetyl)pyridine hydrobromide Preparation Products And Raw materials

Raw materials

4-(Bromoacetyl)pyridine hydrobromideSupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Alfa Aesar
Tel
400-6106006
Email
saleschina@alfa-asia.com
Energy Chemical
Tel
021-021-58432009 400-005-6266
Email
sales8178@energy-chemical.com
Wuhan Chemwish Technology Co., Ltd
Tel
86-027-67849912
Email
sales@chemwish.com
Shanghai Sinch Parmaceuticals Tech. Co. Ltd.
Tel
+86-21-54098501
Email
sales@sinch.com.cn